Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

Contraction of distance and duration production in autism spectrum disorder.

Honma M, Itoi C, Midorikawa A, Terao Y, Masaoka Y, Kuroda T, Futamura A, Shiromaru A, Ohta H, Kato N, Kawamura M, Ono K.

Sci Rep. 2019 Jun 19;9(1):8806. doi: 10.1038/s41598-019-45250-8.

2.

Current Status of Adverse Events Related with Opioid Analgesics in Japan: Assessment Based on Japanese Adverse Drug Event Report Database.

Suga Y, Uchida M, Suzuki S, Sugawara H, Torigoe K, Futamura A, Uesawa Y, Nakagawa T, Takase H.

Biol Pharm Bull. 2019;42(5):801-806. doi: 10.1248/bpb.b18-00997.

3.

The relationship between thyroid function and cerebral blood flow in mild cognitive impairment and Alzheimer's disease.

Nomoto S, Kinno R, Ochiai H, Kubota S, Mori Y, Futamura A, Sugimoto A, Kuroda T, Yano S, Murakami H, Shirasawa T, Yoshimoto T, Minoura A, Kokaze A, Ono K.

PLoS One. 2019 Apr 3;14(4):e0214676. doi: 10.1371/journal.pone.0214676. eCollection 2019.

4.

High serum high-density lipoprotein-cholesterol is associated with memory function and gyrification of insular and frontal opercular cortex in an elderly memory-clinic population.

Kinno R, Mori Y, Kubota S, Nomoto S, Futamura A, Shiromaru A, Kuroda T, Yano S, Ishigaki S, Murakami H, Baba Y, Ono K.

Neuroimage Clin. 2019;22:101746. doi: 10.1016/j.nicl.2019.101746. Epub 2019 Mar 5.

5.

Impaired cognitive modification for estimating time duration in Parkinson's disease.

Honma M, Masaoka Y, Koyama S, Kuroda T, Futamura A, Shiromaru A, Terao Y, Ono K, Kawamura M.

PLoS One. 2018 Dec 13;13(12):e0208956. doi: 10.1371/journal.pone.0208956. eCollection 2018.

6.

The subjective perception of past, present, and future time in patients with Alzheimer's disease: a qualitative study.

Shiromaru-Sugimoto A, Murakami H, Futamura A, Honma M, Kuroda T, Kawamura M, Ono K.

Neuropsychiatr Dis Treat. 2018 Nov 22;14:3185-3192. doi: 10.2147/NDT.S186081. eCollection 2018.

7.

[Musical Hallucinosis].

Futamura A, Kawamura M, Ono K.

Brain Nerve. 2018 Nov;70(11):1147-1156. doi: 10.11477/mf.1416201159. Japanese.

PMID:
30416107
8.

Diagonistic Apraxia: A Unique Case of Corpus Callosal Disconnection Syndrome and Neuromyelitis Optica Spectrum Disorder.

Shozawa H, Futamura A, Saito Y, Honma M, Kawamura M, Miller MW, Ono K.

Front Neurol. 2018 Aug 10;9:653. doi: 10.3389/fneur.2018.00653. eCollection 2018.

9.

Singular case of the driving instructor: Temporal and topographical disorientation.

Futamura A, Honma M, Shiromaru A, Kuroda T, Masaoka Y, Midorikawa A, Miller MW, Kawamura M, Ono K.

Neurol Clin Neurosci. 2018 Jan;6(1):16-18. doi: 10.1111/ncn3.12166. Epub 2017 Dec 12.

10.

Impairment of cross-modality of vision and olfaction in Parkinson disease.

Honma M, Masaoka Y, Kuroda T, Futamura A, Shiromaru A, Izumizaki M, Kawamura M.

Neurology. 2018 Mar 13;90(11):e977-e984. doi: 10.1212/WNL.0000000000005110. Epub 2018 Feb 7.

PMID:
29438044
11.

Differential Effects of the Factor Structure of the Wechsler Memory Scale-Revised on the Cortical Thickness and Complexity of Patients Aged Over 75 Years in a Memory Clinic Setting.

Kinno R, Shiromaru A, Mori Y, Futamura A, Kuroda T, Yano S, Murakami H, Ono K.

Front Aging Neurosci. 2017 Dec 7;9:405. doi: 10.3389/fnagi.2017.00405. eCollection 2017.

12.

Accumulation of 123I-Ioflupane Is a Useful Marker of the Efficacy of Selegiline Monotherapy in Drug-Naïve Parkinson's Disease.

Murakami H, Nohara T, Uchiyama M, Owan Y, Futamura A, Shiromaru A, Tsukada S, Saito Y, Kuroda T, Yano S, Ishigaki S, Katoh H, Munechika J, Ohgiya Y, Gokan T, Ono K.

Front Aging Neurosci. 2017 Sep 29;9:321. doi: 10.3389/fnagi.2017.00321. eCollection 2017.

13.

Identification of highly selective and potent orexin receptor 1 antagonists derived from a dual orexin receptor 1/2 antagonist based on the structural framework of pyrazoylethylbenzamide.

Futamura A, Nozawa D, Araki Y, Tamura Y, Tokura S, Kawamoto H, Tokumaru Y, Kakihara S, Aoki T, Ohtake N.

Bioorg Med Chem. 2017 Oct 15;25(20):5203-5215. doi: 10.1016/j.bmc.2017.07.051. Epub 2017 Jul 29.

PMID:
28807572
14.

Interhemispheric cortical connections and time perception: A case study with agenesis of the corpus callosum.

Okajima M, Futamura A, Honma M, Kawamura M, Yotsumoto Y.

Brain Cogn. 2017 Oct;117:12-16. doi: 10.1016/j.bandc.2017.07.005. Epub 2017 Jul 8.

PMID:
28697375
15.

Spatial distortion related to time compression during spatiotemporal production in Parkinson's disease.

Honma M, Murai Y, Shima S, Yotsumoto Y, Kuroda T, Futamura A, Shiromaru A, Murakami I, Kawamura M.

Neuropsychologia. 2017 Jul 28;102:61-69. doi: 10.1016/j.neuropsychologia.2017.06.004. Epub 2017 Jun 7.

PMID:
28601527
16.

[Clocks, Behavior, and Cognition].

Futamura A, Shiromaru A, Kuroda T, Honma M, Kinno R, Ono K, Kawamura M.

Brain Nerve. 2017 Jun;69(6):639-649. doi: 10.11477/mf.1416200795. Japanese.

PMID:
28596466
17.

Effects of Combined Treatment with Branched-Chain Amino Acids, Citric Acid, L-Carnitine, Coenzyme Q10, Zinc, and Various Vitamins in Tumor-Bearing Mice.

Awa H, Futamura A, Higashiguchi T, Ito A, Mori N, Murai M, Ohara H, Chihara T, Kaneko T.

Biol Pharm Bull. 2017 Mar 1;40(3):266-271. doi: 10.1248/bpb.b16-00638. Epub 2017 Jan 26.

18.

A Clinical Study on Administration of Opioid Antagonists in Terminal Cancer Patients: 7 Patients Receiving Opioid Antagonists Following Opioids among 2443 Terminal Cancer Patients Receiving Opioids.

Uekuzu Y, Higashiguchi T, Futamura A, Ito A, Mori N, Murai M, Ohara H, Awa H, Chihara T.

Biol Pharm Bull. 2017 Mar 1;40(3):278-283. doi: 10.1248/bpb.b16-00715. Epub 2016 Dec 16.

19.

Guidelines for parenteral fluid management for terminal cancer patients.

Higashiguchi T, Ikegaki J, Sobue K, Tamura Y, Nakajima N, Futamura A, Miyashita M, Mori N, Inui A, Ohta K, Hosokawa T.

Jpn J Clin Oncol. 2016 Aug 12. [Epub ahead of print]

PMID:
27521369
20.

[Confabulation: From the Aspect of Disturbance in Time Perception].

Kuroda T, Honma M, Futamura A, Shiromaru-Sugimoto A, Kawamura M.

Brain Nerve. 2016 May;68(5):559-65. doi: 10.11477/mf.1416200438. Review. Japanese.

PMID:
27156509
21.

Dysfunctional counting of mental time in Parkinson's disease.

Honma M, Kuroda T, Futamura A, Shiromaru A, Kawamura M.

Sci Rep. 2016 May 5;6:25421. doi: 10.1038/srep25421.

22.

Improvement in Language Function Correlates with Gait Improvement in Drug-naïve Parkinson's Disease Patients Taking Dopaminergic Medication.

Murakami H, Momma Y, Nohara T, Mori Y, Futamura A, Sugita T, Ishigaki S, Katoh H, Kezuka M, Ono K, Miller MW, Kawamura M.

J Parkinsons Dis. 2016;6(1):209-17. doi: 10.3233/JPD-150702.

PMID:
26889633
23.

Autobiographical age awareness disturbance syndrome in autoimmune limbic encephalitis: two case reports.

Kuroda T, Futamura A, Sugimoto A, Midorikawa A, Honma M, Kawamura M.

BMC Neurol. 2015 Nov 20;15:238. doi: 10.1186/s12883-015-0498-7.

24.

[Cancer and Malnutrition].

Tsuzuki N, Higashiguchi T, Ito A, Ohara H, Futamura A.

Gan To Kagaku Ryoho. 2015 Jul;42(7):791-6. Japanese.

PMID:
26197740
25.

[Diabetes and Dementia].

Futamura A, Mori Y, Kawamura M.

Brain Nerve. 2015 Jun;67(6):725-32. doi: 10.11477/mf.1416200208. Review. Japanese.

PMID:
26062587
26.

[Mental time dysfunction in Parkinson's and Alzheimer's diseases].

Honma M, Kuroda T, Futamura A, Sugimoto A, Kawamura M.

Brain Nerve. 2015 Mar;67(3):297-302. doi: 10.11477/mf.1416200135. Review. Japanese.

PMID:
25846444
27.

Discovery and in vitro and in vivo profiles of N-ethyl-N-[2-[3-(5-fluoro-2-pyridinyl)-1H-pyrazol-1-yl]ethyl]-2-(2H-1,2,3-triazol-2-yl)-benzamide as a novel class of dual orexin receptor antagonist.

Suzuki R, Nozawa D, Futamura A, Nishikawa-Shimono R, Abe M, Hattori N, Ohta H, Araki Y, Kambe D, Ohmichi M, Tokura S, Aoki T, Ohtake N, Kawamoto H.

Bioorg Med Chem. 2015 Mar 15;23(6):1260-75. doi: 10.1016/j.bmc.2015.01.044. Epub 2015 Feb 10.

PMID:
25693785
28.

Influence of serum albumin levels during opioid rotation from morphine or oxycodone to fentanyl for cancer pain.

Hayashi T, Ikehata S, Matsuzaki H, Yasuda K, Makihara T, Futamura A, Arakawa Y, Kuki R, Fukuura K, Takahashi H, Mori N, Higashiguchi T, Yamadaa S.

Biol Pharm Bull. 2014;37(12):1860-5.

PMID:
25590058
29.

Perceiving "ghost" images: a unique case of visual allesthesia with hemianopsia in mitochondrial disease.

Murakami H, Ichikawa H, Sugimoto A, Futamura A, Shimizu Y, Sugie M, Miller MW, Kawamura M.

Neuropsychiatr Dis Treat. 2014 Jun 5;10:999-1002. doi: 10.2147/NDT.S61582. eCollection 2014.

30.

[Successful treatment with anti-epileptic-drug of an 83-year-old man with musical hallucinosis].

Futamura A, Katoh H, Kawamura M.

Brain Nerve. 2014 May;66(5):599-603. Japanese.

PMID:
24807375
31.

[Functional coupling of the frontal and parietal lobes in action].

Futamura A, Kawamura M.

Brain Nerve. 2014 Apr;66(4):451-60. Review. Japanese.

PMID:
24748093
32.

DNA analysis based on toehold-mediated strand displacement on graphene oxide.

Miyahata T, Kitamura Y, Futamura A, Matsuura H, Hatakeyama K, Koinuma M, Matsumoto Y, Ihara T.

Chem Commun (Camb). 2013 Oct 3;49(86):10139-41. doi: 10.1039/c3cc45531a.

PMID:
24048273
33.

[Mental time: a novel approach in neuropsychology].

Kawamura M, Sugimoto A, Futamura A, Midorikawa A.

Brain Nerve. 2013 Aug;65(8):949-55. Review. Japanese.

PMID:
23917497
34.

Rational design for cooperative recognition of specific nucleobases using β-cyclodextrin-modified DNAs and fluorescent ligands on DNA and RNA scaffolds.

Futamura A, Uemura A, Imoto T, Kitamura Y, Matsuura H, Wang CX, Ichihashi T, Sato Y, Teramae N, Nishizawa S, Ihara T.

Chemistry. 2013 Aug 5;19(32):10526-35. doi: 10.1002/chem.201300985. Epub 2013 Jul 2.

PMID:
23821253
35.

Experimental Research on Stimulation of Wound Healing by n-3 Fatty Acids.

Futamura A, Higashiguchi T, Ito A, Kodama Y, Chihara T, Kaneko T, Tomatsu A, Shimpo K.

Wounds. 2013 Jul;25(7):186-92.

PMID:
25867037
36.

[Epilepsy and cognitive dysfunction].

Sugimoto A, Futamura A, Kawamura M.

Brain Nerve. 2013 May;65(5):541-9. Review. Japanese.

PMID:
23667119
37.

[Epilepsy with higher brain dysfunction].

Sugimoto A, Midorikawa A, Koyama S, Futamura A, Kuroda T, Fujita K, Itaya K, Ishigaki S, Kawamura M.

Brain Nerve. 2013 Feb;65(2):195-202. Japanese.

PMID:
23399676
38.

[Epilepsy and dementia].

Sugimoto A, Futamura A, Kawamura M.

Brain Nerve. 2012 Dec;64(12):1399-404. Review. Japanese.

PMID:
23209066
39.

Inhibition of ENNG-induced pyloric stomach and small intestinal carcinogenesis in mice by high temperature- and pressure-treated garlic.

Kaneko T, Shimpo K, Chihara T, Beppu H, Tomatsu A, Shinzato M, Yanagida T, Ieike T, Sonoda S, Futamura A, Ito A, Higashiguchi T.

Asian Pac J Cancer Prev. 2012;13(5):1983-8.

40.

A new disorder of praxis in neurodegenerative disease that may be part of Alzheimer's disease.

Kawai Y, Midorikawa A, Sugimoto A, Futamura A, Sobue G, Kawamura M.

Neurocase. 2013 Aug;19(4):408-15. doi: 10.1080/13554794.2012.690425. Epub 2012 Jul 11.

PMID:
22784356
41.

Picture agnosia as a characteristic of posterior cortical atrophy.

Sugimoto A, Midorikawa A, Koyama S, Futamura A, Hieda S, Kawamura M.

Eur Neurol. 2012;68(1):34-41. doi: 10.1159/000335589. Epub 2012 Jun 15.

PMID:
22710605
42.

Is this a new type of primary prosopagnosia, both progressive and apperceptive?

Sugimoto A, Koyama S, Midorikawa A, Futamura A, Ishiwata K, Ishii K, Miller MW, Kawamura M.

Neuropsychiatr Dis Treat. 2012;8:169-73. doi: 10.2147/NDT.S30541. Epub 2012 Apr 18.

43.

Electrochemical signal modulation in homogeneous solutions using the formation of an inclusion complex between ferrocene and β-cyclodextrin on a DNA scaffold.

Ihara T, Wasano T, Nakatake R, Arslan P, Futamura A, Jyo A.

Chem Commun (Camb). 2011 Dec 7;47(45):12388-90. doi: 10.1039/c1cc15365j. Epub 2011 Oct 20.

PMID:
22012412
44.

[Progressive visual agnosia].

Sugimoto A, Futamura A, Kawamura M.

Brain Nerve. 2011 Oct;63(10):1079-86. Review. Japanese.

PMID:
21987565
45.

Impairment of odor recognition and odor-induced emotions in type 1 myotonic dystrophy.

Masaoka Y, Kawamura M, Takeda A, Kobayakawa M, Kuroda T, Kasai H, Tsuruya N, Futamura A, Homma I.

Neurosci Lett. 2011 Oct 10;503(3):163-6. doi: 10.1016/j.neulet.2011.08.006. Epub 2011 Aug 22.

PMID:
21884754
46.

Prevalence of allergic rhinitis is lower in subjects with higher levels of fasting plasma glucose.

Hashimoto Y, Futamura A.

Diabetes Care. 2010 Nov;33(11):e143. doi: 10.2337/dc10-1338. No abstract available.

PMID:
20980422
47.

Significance of the progression of respiratory symptoms for predicting community-acquired pneumonia in general practice.

Nakanishi M, Yoshida Y, Takeda N, Hirana H, Horita T, Shimizu K, Hiratani K, Toyoda S, Matsumura T, Shinno E, Kawai S, Futamura A, Ota M, Natazuka T.

Respirology. 2010 Aug;15(6):969-74. doi: 10.1111/j.1440-1843.2010.01807.x. Epub 2010 Jul 12.

PMID:
20630031
48.

Cooperative DNA probing using a beta-cyclodextrin-DNA conjugate and a nucleobase-specific fluorescent ligand.

Ihara T, Uemura A, Futamura A, Shimizu M, Baba N, Nishizawa S, Teramae N, Jyo A.

J Am Chem Soc. 2009 Feb 4;131(4):1386-7. doi: 10.1021/ja809023n.

PMID:
19132898
49.

Relationship between response of gamma-glutamyltransferase to alcohol consumption and levels of fasting plasma glucose.

Hashimoto Y, Futamura A.

Diabetes Res Clin Pract. 2008 Jun;80(3):469-72. doi: 10.1016/j.diabres.2008.01.025. Epub 2008 Mar 14.

PMID:
18342385
50.

[Amounts of sweat and salt loss due to sweating during a three-hour badminton practice in summer].

Hashimoto Y, Watanabe N, Futamura A.

Rinsho Byori. 2007 Nov;55(11):1015-8. Japanese.

PMID:
18154033

Supplemental Content

Loading ...
Support Center